RecruitingNCT07685860

Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease

Sponsor

Tianjin Medical University

Enrollment

200 participants

Start Date

Jun 25, 2026

Study Type

OBSERVATIONAL

Conditions

Depression Anxiety Heart Injuries

Summary

To evaluate the potential usefulness of 18F-AIPF-1026 positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-A-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Diagnostic Test: 18F-AIPFA-1026 for people with anxiety, depression, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDiagnostic Test: 18F-AIPFA-1026

Each subject receive a single intravenous injection of 18F-AIPF-1026, and undergo PET/ CT or MRI imaging within the specificed time.

Locations(2)

The First Affiliated Hospital of University of Science and Technology of China

Hefei, Anhui, China

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07685860

Related Trials

Animal Assisted Therapy

NCT072271811 location

An ISO Principle-Based Music Intervention for Reducing Stress, Anxiety, and Depression

NCT070550612 locations